• Home
  • Industry
  • Innovation
  • Market
  • Materials
  • Products
  • Subscribe
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Lost your password?
Forgotten Password
Cancel
  • Home
  • Industry
  • Products
  • Materials
  • Innovation
  • Market
  • Sustainability
  • Regulatory
  • About Us
    • President’s Message
    • The Chemical Daily
  • Subscribe
    • Q & A
    • Subscribe Now
    • Manage my Subscription
    • Subscribe to our E-Mail Newsletter
  • 日本語
    • 化学工業日報
    • 広告掲載について

Coronavirus Report – Part 58: Clinical Trials Begin for Slew of Potential Vaccines

Apr. 24, 2020

Filed Under: Coronavirus Tagged With: coronavirus, drug development, vaccines

Looking to bring an end to the COVID-19 pandemic, countries such as the U.S. and China are ramping up clinical…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Just How Effective Will Vaccines Be in Combating the COVID-19 Pandemic?
Just How Effective Will Vaccines Be in Combating the…
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in Clinical Trials for Early April
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in…
Spate of Japanese-Developed COVID-19 Vaccines Head Into Later Stages of Development, Clinical Trials
Spate of Japanese-Developed COVID-19 Vaccines Head Into…
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…
Coronavirus Report – Part 13: Japanese Companies Start to Develop Vaccines, Treatments
Coronavirus Report – Part 13: Japanese Companies Start to…
Column: COVID-19 Brings Major Changes to Vaccine Development
Column: COVID-19 Brings Major Changes to Vaccine Development
Previous Post: « JSR Sees Increased Proportion of Activist Shareholders Following New Investment
Next Post: Coronavirus Report – Part 59: Fear, Anxiety Linger in Wuhan Despite End of Lockdown »

Primary Sidebar

Latest Articles

Eight Chemical Industry Power Players Combine to Post Record High in Operating Income for FY2021

May. 19, 2022

Interview: Covestro Thailand Managing Director Timo Slawinski Discusses Business Environment, Plans

May. 19, 2022

Half of Local Industry in Shanghai Has Emerged From Lockdown

May. 19, 2022

Japan’s Leading Drug Manufacturers Grow Sales Revenue on Back of Mainstay Products

May. 18, 2022

Mitsubishi Chemical Holdings Targets End of Fiscal 2022 for BN Sheet Commercialization

May. 18, 2022

Most Popular

  • Sumitomo Chemical to Bolster LCP Production, Marketing Activities for EV Use
  • Interview: Mitsubishi Chemical Holdings Corporate Executive Officer Hitoshi Sasaki Discusses MMA Business
  • Interview: Sika CEO Thomas Hasler Talks Strategy
  • Mitsubishi Chemical Holdings Targets End of Fiscal 2022 for BN Sheet Commercialization
  • Sodium Batteries Near Practical Use as Chinese Manufacturers Target Application in EVs and More

Tags

asahi kasei Automotive automotive materials batteries china CO2 CO2 emissions coronavirus electric vehicles environment ethylene EV health care industry trends interview investments LiB LiB materials M&A market conditions medical METI Mitsubishi Chemical Mitsubishi Chemical Holdings Mitsui Chemicals new facilities new materials petrochemical pharmaceutical polypropylene production production increase R&D recycling semiconductors Showa Denko strategy Sumitomo Chemical supply and demand Teijin thailand Toray tosoh U.S. ube industries

Footer

Log In


Lost your password?
Forgotten Password
Cancel

Links

Home
About
広告掲載について
Terms of Use
Privacy Policy
Legal Notice
Notation on the Specified Commercial Transaction Act
Contact us

© 2016–2021 The Chemical Daily Co. Ltd., Bonuterra Inc. All Rights Reserved.

japan-industry-news-network_logo

Copyright © 2022 · Chemical Daily v2 on Genesis Framework · WordPress · Log in